Clinical prognostic factors associated with progression-free survival in pts with metastatic EGFR-mutant non-small cell lung cancer treated with gefitinib first-line therapy.

Authors: Christian Federico Cruz Flores, Maria Luisa Romero, Mario Alberto Sanchez Prieto, Julia Angelina Saenz-Frias, Carlos Horacio Burciaga Flores, Woo Jeong No

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20695

Source: Full article

---

Abstract

e20695